Investors

Press Releases

All Releases

View Summary Regeneron and Sanofi Announce Positive Dupixent® (dupilumab) Phase 3 Atopic Dermatitis Data Published in the New England Journal of Medicine
Oct 1, 2016
PDF 25.1 KB Add to Briefcase
View Summary Regeneron Announces Phase 2 Study of Aflibercept Co-Formulated with Rinucumab (anti-PDGFR-beta) Shows No Benefit Over Aflibercept Alone in Neovascular Age-Related Macular Degeneration
Sep 30, 2016
PDF 27.9 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA
Sep 26, 2016
PDF 18.1 KB Add to Briefcase
View Summary Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
Sep 20, 2016
PDF 22.2 KB Add to Briefcase
View Summary Regeneron Announces Election of Bonnie Bassler, Ph.D., and Huda Zoghbi, M.D., to Board of Directors
Sep 12, 2016
PDF 11.2 KB Add to Briefcase
View Summary Regeneron Announces Upcoming 2016 Investor Conference Presentations
Sep 1, 2016
PDF 9.9 KB Add to Briefcase
View Summary Regeneron and Sanofi Present Positive Phase 3 Investigational Data for Praluent® (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016
Aug 29, 2016
PDF 26.7 KB Add to Briefcase
View Summary Regeneron Announces Agreement with BARDA for the Manufacturing and Testing of New Antibodies Against MERS Virus
Aug 22, 2016
PDF 14.5 KB Add to Briefcase
View Summary Regeneron Reports Second Quarter 2016 Financial and Operating Results
Aug 4, 2016
PDF 55.8 KB Add to Briefcase
View Summary Regeneron and Adicet Bio Announce Strategic Collaboration to Discover and Develop Next-Generation Engineered Immune Cell Therapeutics
Aug 2, 2016
PDF 35.6 KB Add to Briefcase
View Summary Regeneron Announces Upcoming 2016 Investor Conference Presentation
Jul 18, 2016
PDF 9.9 KB Add to Briefcase
View Summary Regeneron Announces 2016 Winners of the Regeneron Prize for Creative Innovation
Jul 13, 2016
PDF 13.1 KB Add to Briefcase
View Summary Award-Winning Chef Elizabeth Falkner Reveals Her Struggle with Atopic Dermatitis to Highlight the Physical and Psychological Impact of the Disease
Jul 12, 2016
PDF 16.8 KB Add to Briefcase
View Summary Regeneron to Report Second Quarter 2016 Financial and Operating Results and Host Conference Call and Webcast on August 4, 2016
Jul 8, 2016
PDF 8.6 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Jul 5, 2016
PDF 24.1 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce that Dupilumab Used with Topical Corticosteroids (TCS) was Superior to Treatment with TCS Alone in Long-term Phase 3 Trial in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients
Jun 6, 2016
PDF 25.0 KB Add to Briefcase
View Summary Regeneron Presents Positive Interim Data from Phase 2 Proof-of-Concept Study of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia
May 31, 2016
PDF 14.8 KB Add to Briefcase
View Summary Regeneron Selected by Society for Science & the Public as New Sponsor of the Science Talent Search
May 26, 2016
PDF 17.6 KB Add to Briefcase
  Words of Support from Public Figures on Regeneron STS Sponsorship
May 26, 2016
PDF 122.8 KB Add to Briefcase
  Regeneron Announces Important US Prescribing Information Clarification for EYLEA® (aflibercept) Injection
May 25, 2016
PDF 116.7 KB Add to Briefcase
Showing 1-20 of 350 Page: 1 2 3 4 5 ... 18  Next 20
Add to Briefcase = add release to Briefcase


Close
Form content here please :)